KCP can also act positively on the downstream gene SERPINB3 and negatively on the downstream gene CEBPA to participate in the proliferative function of cervical squamous carcinoma cells and affect the resistance of cervical carcinoma to paclitaxel. The gene discussed is CEBPA; the disease is cervical carcinoma.